Silverarc Capital Management, LLC Akero Therapeutics, Inc. Transaction History

Silverarc Capital Management, LLC

$411 Million
Q1 2025

A detailed history of Silverarc Capital Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 719,992 shares of AKRO stock, worth $37.1 Million. This represents 7.1% of its overall portfolio holdings.

Number of Shares

719,992

Previous 739,563 2.65%

Holding current value

$37.1 Million

Previous $20.6 Million 41.66%

% of portfolio

7.1%

Previous 4.95%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$21.87 - $57.56 $428,017 - $1.13 Million	-19,571 Reduced 2.65%	719,992 $29.1 Million
Q4 2024 Feb 14, 2025	BUY	$26.75 - $35.28 $2.67 Million - $3.52 Million	99,723 Added 15.59%	739,563 $20.6 Million
Q3 2024 Nov 14, 2024	BUY	$21.45 - $29.34 $316,451 - $432,853	14,753 Added 2.36%	639,840 $18.4 Million
Q2 2024 Aug 14, 2024	BUY	$18.31 - $24.62 $4.12 Million - $5.54 Million	225,138 Added 56.29%	625,087 $14.7 Million
Q1 2024 May 14, 2024	BUY	$17.76 - $31.18 $2.68 Million - $4.7 Million	150,695 Added 60.46%	399,949 $10.1 Million
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $2.48 Million - $11 Million	217,918 Added 695.42%	249,254 $5.82 Million
Q3 2023 Nov 13, 2023	SELL	$41.19 - $52.25 $8.65 Million - $11 Million	-210,021 Reduced 87.02%	31,336 $1.58 Million
Q2 2023 Aug 14, 2023	BUY	$36.89 - $56.88 $1.43 Million - $2.21 Million	38,796 Added 19.15%	241,357 $11.3 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $1.14 Million - $1.53 Million	30,461 Added 17.7%	202,561 $7.75 Million
Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $4.28 Million - $7.01 Million	-127,900 Reduced 42.63%	172,100 $9.43 Million
Q3 2022 Oct 28, 2022	BUY	$10.15 - $34.05 $402,701 - $1.35 Million	39,675 Added 15.24%	300,000 $10.2 Million
Q2 2022 Jul 25, 2022	BUY	$8.0 - $15.01 $2.08 Million - $3.91 Million	260,325 New	260,325 $2.46 Million
Q3 2021 Nov 15, 2021	SELL	$18.65 - $25.46 $615,972 - $840,892	-33,028 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$24.81 - $32.35 $25,504 - $33,255	1,028 Added 3.21%	33,028 $819,000
Q1 2021 May 18, 2021	SELL	$24.04 - $34.19 $76,423 - $108,690	-3,179 Reduced 9.04%	32,000 $928,000
Q4 2020 Feb 16, 2021	BUY	$25.12 - $29.89 $883,696 - $1.05 Million	35,179 New	35,179 $908,000

Others Institutions Holding AKRO

# of Institutions

269

Shares Held

86M

Call Options Held

1.02M

Put Options Held

823K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.39B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Account

Silverarc Capital Management, LLC Akero Therapeutics, Inc. Transaction History